Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...

Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement under stricte...

The Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company resp...

Data revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.

"We are open, we have the capacity" Bancel said about supplying its mRNA-based shots to the country, declining to say whether Moderna had s...

Now that kids under 6 are the only strata of population that still does not have a vaccine, this move by Moderna might just be the final pi...

The Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a seco...

Moderna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...

Moderna plans to apply for separate U.S. regulatory clearance in children ages 6 through 11 "very soon," Bancel said, adding that he is hop...

"We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents," ...

The study "showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identifi...

Speaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to...

Pfizer, which makes a similar COVID-19 vaccine, has previously reported that its shot also appears effective against the strain from Britai...

On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions...

The Amsterdam-based EMA will have to study test results before recommending that Brussels gives its approval, but -- speaking after talks w...

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...

Novel cancer drugs often come with six-figure price tags, so success could be lucrative. Numerous companies are chasing a cancer vaccine. O...